Part,  Chapter, Paragraph

1   II,     5.  5.  3| authors concluded that the dose-response relationship suggests a
2   II,     5.  5.  3| and Parkinson’s disease: a dose-response relationship. Neurology
3  III,    10.  4.  2|    extrapolation of cancer dose-response data. EFSA then discussed
4  III,    10.  4.  2|  the point selected on the dose-response curve and the measure(s)
5  III,    10.  4.  2|  benefit characterisation (dose-response assessment), exposure assessment,